1. Home
  2. FSP vs CALC Comparison

FSP vs CALC Comparison

Compare FSP & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

HOLD

Current Price

$0.79

Market Cap

94.6M

Sector

Real Estate

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$0.61

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSP
CALC
Founded
1981
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.6M
88.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FSP
CALC
Price
$0.79
$0.61
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
349.4K
2.8M
Earning Date
02-11-2026
11-12-2025
Dividend Yield
4.80%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$109,497,000.00
N/A
Revenue This Year
$4.36
N/A
Revenue Next Year
$0.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$0.59
52 Week High
$2.09
$7.20

Technical Indicators

Market Signals
Indicator
FSP
CALC
Relative Strength Index (RSI) 29.75 17.64
Support Level $0.82 $0.59
Resistance Level $0.92 $5.95
Average True Range (ATR) 0.04 0.41
MACD -0.01 -0.60
Stochastic Oscillator 4.17 0.57

Price Performance

Historical Comparison
FSP
CALC

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: